InvestorsHub Logo
Followers 74
Posts 6292
Boards Moderated 0
Alias Born 03/20/2005

Re: None

Thursday, 04/21/2016 9:19:14 AM

Thursday, April 21, 2016 9:19:14 AM

Post# of 34575
TapImmune Announces Phase 2 Ovarian Cancer Trial Study with AstraZeneca/MedImmune and Sloan Kettering Cancer Institute
Published: Apr 21, 2016 9:15 a.m. ET
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News